These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9030902)

  • 1. Modulation of the inflammatory response by corticotropin-releasing factor.
    Correa SG; Riera CM; Spiess J; Bianco ID
    Eur J Pharmacol; 1997 Jan; 319(1):85-90. PubMed ID: 9030902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of anti-inflammatory drugs on rat hind-paw swelling caused by phospholipase A2 from Naja naja atra venom.
    Wang JP; Teng CM
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):377-81. PubMed ID: 1683689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin-releasing factor inhibits the acute inflammatory response of rat pawskin to cold injury.
    Serda SM; Wei ET
    Cryobiology; 1991 Apr; 28(2):185-90. PubMed ID: 2070621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of carrageenin-induced rat paw oedema by crotapotin, a polypeptide complexed with phospholipase A2.
    Landucci EC; Antunes E; Donato JL; Faro R; Hyslop S; Marangoni S; Oliveira B; Cirino G; de Nucci G
    Br J Pharmacol; 1995 Feb; 114(3):578-83. PubMed ID: 7537590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral anti-inflammatory actions of corticotropin-releasing factor.
    Wei ET; Gao GC; Thomas HA
    Ciba Found Symp; 1993; 172():258-68; discussion 268-76. PubMed ID: 7683982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin-releasing factor: an inhibitor of vascular leakage in rat skeletal muscle and brain cortex after injury.
    Wei ET; Gao GC
    Regul Pept; 1991 Apr; 33(2):93-104. PubMed ID: 1882088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing factor inhibits thermal injury.
    Kiang JG; Wei ET
    J Pharmacol Exp Ther; 1987 Nov; 243(2):517-20. PubMed ID: 3500298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2.
    Tsatsanis C; Androulidaki A; Dermitzaki E; Gravanis A; Margioris AN
    J Cell Physiol; 2007 Mar; 210(3):774-83. PubMed ID: 17117478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective actions of corticotropin-releasing factor on thermal injury to rat pawskin.
    Wei ET; Serda S; Tian JQ
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1082-5. PubMed ID: 3264573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin-releasing factor inhibits neurogenic plasma extravasation in the rat paw.
    Wei ET; Kiang JG; Buchan P; Smith TW
    J Pharmacol Exp Ther; 1986 Sep; 238(3):783-7. PubMed ID: 2875171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urocortin, a corticotropin-releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats.
    Turnbull AV; Vale W; Rivier C
    Eur J Pharmacol; 1996 May; 303(3):213-6. PubMed ID: 8813571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased inflammatory responsiveness of hypophysectomized rats to heat is reversed by a corticotropin-releasing factor (CRF) antagonist.
    Wei ET; Wong JC; Kiang JG
    Regul Pept; 1990 Mar; 27(3):317-23. PubMed ID: 1970186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptides of the corticoliberin superfamily attenuate thermal and neurogenic inflammation in rat pawskin.
    Wei ET; Kiang JG
    Eur J Pharmacol; 1989 Sep; 168(1):81-6. PubMed ID: 2583234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local injections of corticotropin releasing factor reduce doxorubicin-induced acute inflammation in the eyelid.
    McLoon LK; Wirtschafter J
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):834-41. PubMed ID: 9112978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute inflammatory response of the rat pawskin to acid injury is attenuated by corticotropin-releasing factor.
    Tian JQ; Wei ET
    Drug Chem Toxicol; 1989 Mar; 12(1):61-6. PubMed ID: 2785449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide specificity for stimulation of corticotropin secretion: activation of overlapping pathways by the vasoactive intestinal peptide family and corticotropin-releasing factor.
    Westendorf JM; Schonbrunn A
    Endocrinology; 1985 Jun; 116(6):2528-35. PubMed ID: 2859986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue.
    Schäfer M; Carter L; Stein C
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4219-23. PubMed ID: 7910403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of ischemic reperfusion edema with corticotropin-releasing factor (CRF) in rat hind limb replantation.
    Whitney TM; Wang KK; Sternbach Y; Chaklis-Haley D
    Ann Plast Surg; 1997 Apr; 38(4):416-9; discussion 419-20. PubMed ID: 9111904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of luteinizing-hormone-releasing hormone, alpha-melanocyte-stimulating hormone, naloxone, dexamethasone and indomethacin on interleukin-2-induced corticotropin-releasing factor release.
    Karanth S; Lyson K; Aguila MC; McCann SM
    Neuroimmunomodulation; 1995; 2(3):166-73. PubMed ID: 8646567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute stress modulates the histamine content of mast cells in the gastrointestinal tract through interleukin-1 and corticotropin-releasing factor release in rats.
    Eutamene H; Theodorou V; Fioramonti J; Bueno L
    J Physiol; 2003 Dec; 553(Pt 3):959-66. PubMed ID: 14555722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.